Abbott gains CE approval for dual-chamber leadless pacemaker [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
This provides an opportunity for Abbott to compete with Medtronic, which currently has a monopoly on the market with its Micra AV product line. The dual-chamber leadless pacemaker market was worth $185.9 million globally in 2023 and is projected to reach sales of $438 million in 2033 at a compound annual growth rate (CAGR) of 8.95%, according to GlobalData, a leading data and analytics company. The overall pacemaker market has shown stable growth in recent years, and this is expected to continue for the foreseeable future. The growth is due to the growing population at risk of cardiovascular diseases and continuing advancements in technology that improve upon the current limitations of pacemaker systems. In turn, this will also promote growth in the dual chamber leadless market, as the drivers of the market remain relatively the same. One barrier to this growth is the cost of dual-chamber leadless pacemakers. However, future technological advancements in this space will likely drive
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Meal Replacement Market to Hit $20.52 billion by 2031, at a CAGR of 5.6%, says Coherent Market Insights [Yahoo! Finance]Yahoo! Finance
- Europe Baby Food and Infant Formula Market Report 2024-2032: Growing Preference for Organic Baby Food Contributing to Growth [Yahoo! Finance]Yahoo! Finance
- Genetic Testing Market to Surpass USD 36.40 Billion by 2031, Witnessing 22% CAGR Growth | SkyQuest Technology [Yahoo! Finance]Yahoo! Finance
- Abbott (ABT) Exceeds Market Returns: Some Facts to Consider [Yahoo! Finance]Yahoo! Finance
- Inflammatory Bowel Disease Market size is set to grow by USD 7.61 billion from 2024-2028, Increasing incidence of ibd worldwide to boost the market growth, Technavio [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 4/17/24 - Beat
ABT
Sec Filings
- 6/25/24 - Form 11-K
- 5/30/24 - Form SD
- 5/14/24 - Form 4
- ABT's page on the SEC website